390 related articles for article (PubMed ID: 33126517)
21. Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors.
Fan J; Wei Q; Liao J; Zou Y; Song D; Xiong D; Ma C; Hu X; Qu X; Chen L; Li L; Yu Y; Yu X; Zhang Z; Zhao C; Zeng Z; Zhang R; Yan S; Wu T; Wu X; Shu Y; Lei J; Li Y; Zhang W; Haydon RC; Luu HH; Huang A; He TC; Tang H
Oncotarget; 2017 Apr; 8(16):27105-27119. PubMed ID: 28404920
[TBL] [Abstract][Full Text] [Related]
22. LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis.
Chen Z; Yao L; Liu Y; Zhu P
Cancer Lett; 2018 Aug; 430():88-96. PubMed ID: 29778568
[TBL] [Abstract][Full Text] [Related]
23. Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.
Ram Makena M; Gatla H; Verlekar D; Sukhavasi S; K Pandey M; C Pramanik K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480221
[TBL] [Abstract][Full Text] [Related]
24. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.
Peng Y; Zhang X; Feng X; Fan X; Jin Z
Oncotarget; 2017 Feb; 8(8):14089-14106. PubMed ID: 27793042
[TBL] [Abstract][Full Text] [Related]
25. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
26. WNT as a Driver and Dependency in Cancer.
Parsons MJ; Tammela T; Dow LE
Cancer Discov; 2021 Oct; 11(10):2413-2429. PubMed ID: 34518209
[TBL] [Abstract][Full Text] [Related]
27. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
28. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.
Duchartre Y; Kim YM; Kahn M
Methods Mol Biol; 2017; 1613():463-478. PubMed ID: 28849572
[TBL] [Abstract][Full Text] [Related]
30. Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides.
Yadav V; Jobe N; Mehdawi L; Andersson T
Handb Exp Pharmacol; 2021; 269():279-303. PubMed ID: 34455485
[TBL] [Abstract][Full Text] [Related]
31. Wnt Signaling and Drug Resistance in Cancer.
Zhong Z; Virshup DM
Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
[TBL] [Abstract][Full Text] [Related]
32. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Krishnamurthy N; Kurzrock R
Cancer Treat Rev; 2018 Jan; 62():50-60. PubMed ID: 29169144
[TBL] [Abstract][Full Text] [Related]
34. A New Wave of Targeting 'Undruggable' Wnt Signaling for Cancer Therapy: Challenges and Opportunities.
Park WJ; Kim MJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190019
[TBL] [Abstract][Full Text] [Related]
35. The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities.
Yu M; Qin K; Fan J; Zhao G; Zhao P; Zeng W; Chen C; Wang A; Wang Y; Zhong J; Zhu Y; Wagstaff W; Haydon RC; Luu HH; Ho S; Lee MJ; Strelzow J; Reid RR; He TC
Genes Dis; 2024 May; 11(3):101026. PubMed ID: 38292186
[TBL] [Abstract][Full Text] [Related]
36. WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway.
Sarabia-Sánchez MA; Robles-Flores M
Stem Cell Rev Rep; 2024 Jan; 20(1):52-66. PubMed ID: 37804416
[TBL] [Abstract][Full Text] [Related]
37. Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.
Li J; Ji L; Chen J; Zhang W; Ye Z
Biomed Res Int; 2015; 2015():964842. PubMed ID: 26078973
[TBL] [Abstract][Full Text] [Related]
38. Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
Disoma C; Zhou Y; Li S; Peng J; Xia Z
Biochimie; 2022 Apr; 195():39-53. PubMed ID: 35066101
[TBL] [Abstract][Full Text] [Related]
39. The microRNA regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases.
Mahmood S; Bhatti A; Syed NA; John P
J Recept Signal Transduct Res; 2016; 36(3):310-8. PubMed ID: 26523375
[TBL] [Abstract][Full Text] [Related]
40. WNT signaling: an emerging mediator of cancer cell metabolism?
Sherwood V
Mol Cell Biol; 2015 Jan; 35(1):2-10. PubMed ID: 25348713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
